Everyone’s building a ‘GPT for cells.’ Relation’s bet is manufacturing the data to train it.

The race to build an AI “foundation model of the cell” has a fuel problem. The biological data needed to train one is scarce, messy and inconsistent. Relation Therapeutics thinks the answer is to manufacture that data itself, and GSK is paying up to $110m to help. The London startup unveiled two things at once […]
This story continues at The Next Web